Bibliografía:
- Teleflex Internal Data on File 2014.
- Davidoff J, Fowler R, Gordon D, Klein G, Kovar J, Lozano M, Potkya J, Racht E, Saussy J,
Swanson E, Yamada R, Miller L. Clinical evaluation of a novel intraosseous device for adults:
prospective, 250-patient, multi-center trial. JEMS 2005;30(10):s20-3. Research sponsored by
Teleflex Incorporated.
- Montez D, Puga T, Miller LJ, et al. Intraosseous Infusions from the Proximal Humerus Reach the
Heart in Less Than 3 Seconds in Human Volunteers. Annals of Emergency Medicine 2015;66(4S):S47.
Research sponsored by Teleflex Incorporated.
- Cooper BR, Mahoney PF, Hodgetts TJ, Mellor A. Intra-osseous access (EZ-IO) for
resuscitation: UK military combat experience. J R Army Med Corps. 2007;153(4):314-316
- Hoskins SL, Nascimento P Jr., Lima RM, Espana-Tenorio, JM, Kramer GC. Pharmacokinetics of
intraosseous and central venous drug delivery during cardiopulmonary resuscitation.
Resuscitation 2011; doi:10.1016/j.resuscitation.2011.07.041. Research sponsored by Teleflex
Incorporated. (preclinical study)
- Hoskins SL, Zachariah BS, Copper N, Kramer GC. Comparison of intraosseous proximal humerus and
sternal routes for drug delivery during CPR. Circulation 2007; 116:II_993. Research sponsored by
Teleflex Incorporated. (preclinical study)
*En comparación con catéteres venosos centrales (CVC) de lumen
único.
†Basado en datos de inserción con el sistema EZ-IO en
húmero proximal en pacientes adultos.
Needle Vise es una marca comercial o registrada de Atrion Medical Products,
Inc.
Teleflex, el logotipo de Teleflex, Arrow, DispoLED, EZ-IO, Hudson RCI, LMA, LMA Supreme, MAD, MAD Nasal y Rüsch son marcas comerciales o registradas de Teleflex Incorporated o sus afiliados en Estados Unidos y otros países. MCI-100359